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AbSTrACT
background: Early diagnosis and treatment of congenital heart 
defects have a well-known impact on patient´s quality of life. 
This study aimed to describe the population of patients with 
congenital heart disease submitted to percutaneous diagnostic 
or therapeutic procedures at a tertiary referral center. Methods: 
Retrospective analysis of 1,002 patients submitted to cardiac 
catheterization between 2003 and 2009 at Instituto de Cardiologia 
do Rio Grande do Sul. Clinical, demographic and procedure 
variables were obtained from an institutional database and 
patient charts. results: Median age was 33 (0-73) years and 
median weight was 23 (9.6-52.6) kg. Patients were predomi-
nantly females (52%), with acyanotic heart disease (63.2%) and 
postnatal diagnosis (94.8%). Pulmonary stenosis (22.9%), atrial 
septal defect (22.5%) and patent ductus ateriosus (21.6%) were 
the most common acyanotic heart defects, whereas tetralogy of 
Fallot was the most frequent cyanotic heart disease (15,2%). Most 
of the procedures (58,6%) were therapeutic, including pulmo-
nary balloon valvuloplasty (32.9%), atrial septal defect closure 
(20.9%) and ductus arteriosus closure (15%). Complications 
were observed in 19.2% of patients, and inguinal hematomas 
(7.8%) and fever (7.6%) were the most frequent findings. There 
were 3 procedure-related deaths (0.3%). Conclusions: The study 
results demonstrated the prevalence of therapeutic procedures 
in patients with acyanotic heart disease, performed with a low 
complication rate at a tertiary referral center.
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rESUMO
Perfil de Pacientes com Cardiopatia Congênita 
Submetidos a Procedimentos Percutâneos em um 
Centro Terciário: Análise de 1.002 Casos
Introdução: O diagnóstico precoce e o tratamento dos defeitos 
cardíacos congênitos têm reconhecido impacto na qualidade 
de vida dos pacientes. Nosso objetivo foi descrever a popu-
lação de pacientes com cardiopatias congênitas submetidos a 
procedimentos diagnósticos ou terapêuticos percutâneos em 
um centro terciário. Métodos: Análise retrospectiva de 1.002 
pacientes submetidos a cateterismo cardíaco no período de 
2003 a 2009 no Instituto de Cardiologia do Rio Grande do Sul. 
Variáveis demográficas, clínicas e do procedimento foram obtidas 
a partir de um banco de dados institucional e dos prontuários 
dos pacientes. resultados: A mediana de idade dos pacientes 
foi de 33 (0-73) anos e a de peso, de 23 (9,6-52,6) kg. Houve 
predominância do sexo feminino (52%), de doença acianótica 
(63,2%) e de diagnóstico realizado no período pós natal (94,8%). 
Estenose pulmonar (22,9%), comunicação interatrial (22,5%) 
e persistência do canal arterial (21,6%) foram os defeitos 
acianóticos mais comuns, e tetralogia de Fallot foi a doença 
cianótica mais frequente (15,2%). A maioria dos procedimentos 
(58,6%) foi terapêutica, incluindo valvuloplastias pulmonares 
(32,9%), fechamento de comunicações interatriais (20,9%) e 
fechamento de persistências do canal arterial (15%). Em 19,2% 
dos pacientes foram observadas complicações, sendo os hema-
tomas inguinais (7,8%) ou a febre (7,6%) as mais frequentes. 
Ocorreram 3 óbitos (0,3%) relacionados aos procedimentos. 
Conclusões: Os resultados deste estudo evidenciaram a pre-
dominância de procedimentos terapêuticos em pacientes com 
cardiopatias congênitas acianóticas, realizados com baixo índice 
de complicações, em centro terciário de referência.
DESCrITOrES: Cardiopatias congênitas. Perfil de saúde. 
Cateterismo.
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C ongenital heart defects affect approximately nine per 1,000 live births.1,2 Approximately 20% to 30% of untreated children with heart disease die 
within the first month of life.3 Early diagnosis is crucial 
to prevent and minimize the complications of rapid 
clinical deterioration and to reduce the high rates of 
morbidity and mortality.4 
Interventional cardiology offers diagnostic proce-
dures in cases where traditional assessment methods 
are inadequate, and in cases in which manometric 
evaluation is critical. Furthermore, therapeutic percuta-
neous procedures postpone or even prevent the need 
to perform more invasive surgical procedures.5 The 
growing number of congenital heart defects amenable 
to percutaneous treatment, together with the low num-
ber of complications, reduced hospitalization time, and 
reduced hospitalization costs, have made percutaneous 
interventions an excellent therapeutic option with good 
results in the short and long term.5-8
This study aimed to evaluate the profile of patients 
with congenital heart disease undergoing percutaneous 
diagnostic or therapeutic procedures in a pediatric 
cardiology referral centre.
Methods
This cross-sectional retrospective study assessed 
the demographic and clinical profiles and outcomes 
of adult and pediatric patients with congenital heart 
disease undergoing percutaneous diagnostic or thera-
peutic procedures performed between 2003 and 2009 
in a referral cardiology hospital.
Initially, the interventional pediatric cardiology 
service’s database was searched, and information was 
collected to characterize the sample. Then, additional 
information was collected from the records of the Depart-
ment of Medical Files (SAME). Variables were obtained 
related to clinical and demographic characteristics, 
including gender, age, ethnicity, origin, anthropometric 
measurements (weight, height, blood pressure, and heart 
rate), associated comorbidities, previous surgeries and 
hospitalizations, established medical diagnosis, number 
and type of percutaneous procedures performed, pros-
theses used, and clinical events during hospitalization.
A sample size calculation used the proportion of 
50% of the total population of 1,961 patients, with 
a margin of error of 2.2% and a confidence level of 
95%, totalling 987 patients. To account for possible 
follow-up losses due to incomplete records, a sample 
of 1,002 patients was used.
This research was developed according to the Guide-
lines and Standards for Research Involving Human Subjects, 
as stated in Resolution 196/96. The project was approved 
by the ethics and research committee under registration 
number 4.431/09. The authors signed the term form for the 
use of patient records and databases for research projects.
Statistical analyses were performed using SPSS, 
release 15.0. Categorical variables were expressed as 
absolute values and percentages, whereas quantitative 
variables were expressed as the mean and standard 
deviation or the median and 25th and 75th percentiles, 
when their distributions were normal or non-normal, 
respectively.
Results
A total of 1,002 cases of congenital heart disease 
submitted to percutaneous interventional and diagnostic 
procedures were evaluated. Among these patients, 521 
(52%) were female. The median age was 33 (0-73) years. 
Most patients (94.8%) received a heart disease diagnosis 
after birth. Among the comorbidities evaluated, the most 
commonly found were pulmonary diseases (10.6% of 
patients) and systemic arterial hypertension (10.2% of 
patients). Down syndrome was the most frequent ge-
netic syndrome, present in 4.2% of the cases (Table 1).
The most prevalent acyanotic congenital heart 
diseases were pulmonary stenosis (22.9% of patients), 
atrial septal defect (22.5% of patients), and patent ductus 
arteriosus (21.6% of patients), all evaluated separately. 
Among the cyanotic congenital heart diseases, tetralogy 
of Fallot (15.2% of patients) was the most common, 
followed by pulmonary atresia (10.8% of patients), and 
transposition of the great arteries (5.7% of patients) 
(Table 2).
Table 1 
Clinical characteristics of the population  
with congenital heart disease
Characteristics n = 1,002
Female gender, n (%) 521 (52)
White, n (%) 936 (93.4)
Age, n (%)
< 1 month 57 (5.7)
≥ 1 month e < 1 year 58 (5.8)
≥ 1 year e < 5 years 251 (25)
≥ 5 years e < 10 years 192 (19.2)
≥ 10 years e < 20 years 242 (24.2)
≥ 20 years 202 (20.2)
Postnatal diagnosis, n (%) 950 (94.8)
Comorbidities, n (%)
Pulmonary diseases 106 (10.6)
Systemic arterial hypertension 102 (10.2)
Down syndrome 42 (4.2)
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When evaluating data related to percutaneous pro-
cedures, it was observed that 587 procedures (58.6%) 
were therapeutic, of which 193 (32.9%) were pulmonary 
valvuloplasties, 123 (20.9%) were septal closures, and 
88 (15%) were closures of the ductus arteriosus. The 
average procedure duration was 75 (60-90) minutes 
and the mean length of hospitalization was four (three 
to nine) days (Table 3). Therapeutic procedures are 
described in Table 4.
The present results demonstrated that the most 
prevalent complications related to percutaneous 
procedures were hematomas at the access route (7.8% 
of patients) and fever (7.6% of patients). All episodes 
of fever were isolated and were not associated with 
procedure-related infections. Complications associated 
with diagnostic and therapeutic percutaneous procedures 
are described in Table 5.
The arrhythmias or conduction disorders observed 
at examination were left bundle branch block, atrial 
fibrillation, atrial flutter, bradycardia, atrioventricular 
block, supraventricular tachycardia, and ventricular 
fibrillation. All arrhythmias were treated or resolved 
spontaneously during the procedure.
discussion
The present study observed a predominance of 
patients with pulmonary stenosis, atrial septal defect, or 
patent ductus arteriosus. Previous studies9,10 that assessed 
populations with similar characteristics, but in clinical 
and/or surgical patients, showed that ventricular septal 
defect (VSD) was the most frequent congenital heart 
disease, which is dissimilar from the present findings. 
However, these previous studies observed similar results 
regarding the incidence of cyanotic heart disease; tetralogy 
of Fallot was the most prevalent among these defects.
The fact that VSD was not the most common con-
genital heart defect is also noteworthy. Although VSD is 
the most prevalent, in general, this population currently 
requires only echocardiography for the diagnosis and 
does not require cardiac catheterization. Moreover, 
percutaneous VSD closure is not yet a reality for the 
patients attended to at the Brazilian Unified Health 
System (Sistema Único de Saúde – SUS).7
The present results demonstrated that the congenital 
heart disease diagnosis was made predominantly in the 
postnatal period, among 1 to 5 years aged children. 
During this period, a congenital heart disease diagnosis 
is obtained more frequently, and most percutaneous 
therapeutic procedures are performed.11,12 Thus, in some 
cases, percutaneous procedures represent a less invasive 
Table 2 
Types of congenital heart disease diagnosed  
or percutaneously treated
Congenital heart diseases n = 1,002
Acyanotic, n (%)
Pulmonary stenosis 229 (22.9)
Atrial septal defect 225 (22.5)
Patent ductus arteriosus 216 (21.6)
Ventricular septal defect 194 (19.4)
Aorta coarctation 106 (10.6)
Patent foramen ovale 82 (8.2)
Aortic stenosis 61 (6.1)
Atrioventricular septal defect 25 (2.5)
Left ventricular hypoplasia 21 (2.1)
Double inlet left ventricle 18 (1.8)
Ebstein anomaly 13 (1.3)
Coronary anomaly 11 (1.1)
Subaortic fibrosis 9 (0.9)
Dilated cardiomyopathy 9 (0.9)
Mitral atresia 8 (0.8)
Partial pulmonary anomalous venous 
drainage
8 (0.8)
Truncus arteriosus 7 (0.7)
Interrupted aortic arch 4 (0.4)
Shone’s syndrome 1 (0.1)
Cyanotic, n (%)
Tetralogy of Fallot 152 (15.2)
Pulmonary atresia 108 (10.8)
Transposition of great arteries 57 (5.7)
Double outlet right ventricle 51 (5.1)
Tricuspid atresia 34 (3.4)
Table 3 
Characteristics of percutaneous  
therapeutic procedures
Characteristics n = 587
Devices used, n (%)
Septal occluders 207 (35.3)
Stents 115 (19.6)
Spring coils 64 (10.9)
Ductal occluders 27 (4.6)
Duration of procedure, min 75 (60-90)
Time of hospitalization, days 4 (3-9)
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repair of atrial septal defect are noteworthy.7 These data 
reinforce the importance of these therapies in reducing 
post-procedural comorbidities and length of hospitaliza-
tion.13 In developed countries, percutaneous repair of atrial 
septal defect is certainly the most economical option due 
to the lower rates of complications and shorter recovery 
time. Percutaneous repair also provides greater comfort 
for patients and has a similar efficacy to the surgical 
technique. However, in developing countries, the cost of 
the prosthesis is still the main obstacle to the procedure.7
An important result in the present study was the 
occurrence of minor complications, such as hema-
tomas, fever, and arrhythmias, which were quickly 
resolved without clinical consequences for patients. 
The evolution of techniques and devices in paediatric 
interventional cardiology, such as the use of stents, 
balloons, and prostheses, has ensured safer procedures 
with fewer complications by offering other modes of 
cardiac structure visualization.14,15
Percutaneous interventions improve quality of life, 
relieve symptoms, and increase the survival of children 
with greater clinical complexity in different therapeutic 
modalities, either as an adjunct therapy or by delaying 
surgical interventions. The prevention of complications 
after coronary interventions should be a concern of health 
professionals who work in paediatric interventional car-
diology, as these complications have a significant impact 
on patients’ bed confinement, prolonging hospitalization, 
and increasing medical and nursing procedures. It is 
necessary to develop care protocols to minimize the 
predictors of complications and standardize multidisci-
plinary care for this group of patients.
intervention, without the immediate indication of more 
aggressive procedures, such as surgical procedures.
Most percutaneous therapeutic procedures performed 
in this service setting were pulmonary valvuloplasty, 
closure of atrial septal defect, and closure of patent 
ductus arteriosus. These data are similar to those of 
a previously described study,10 which aimed to define 
the profile of patients with congenital heart disease in 
a referral centre in Southern Brazil, but in that study, 
both percutaneous and surgical therapeutic procedures 
were evaluated.
In addition to these procedures, the excellent im-
mediate and long-term results achieved by percutaneous 
Table 4 
Treated diseases and devices used in the procedures 
Procedure n = 587
ASD closure, n (%) 123 (20.9)
Septal occluders 121 (20.6)
No prosthesis was implanted 2 (0.3)
VSD closure, n (%) 7 (1.2)
Spring coils 2 (0.3)
Septal occluders 5 (0.9)
PFO closure, n (%) 54 (9.2)
Septal occluders 54 (9.2)
PDA closure, n (%) 88 (15)
Spring coils 61 (10.4)
Ductal occluders 27 (4.6)
Aortic repair, n (%) 65 (11.1)
Stents 37 (6.3)
Balloon 28 (4.8)
Pulmonary valvuloplasty with  
balloon-catheter, n (%)
193 (32.9)
Pulmonary artery percutaneous 
stenting, n (%)
62 (10.6)
Atrioseptostomy, n (%) 10 (1.7)
Balloon 8 (1.4)
Stents 2 (0.3)
Stent implantation in the ductus 
arteriosus, n (%)
14 (2.4)
Aortic valvuloplasty with  
balloon-catheter, n (%)
29 (4.9)
ASD, atrial septal defect; VSD, ventricular septal defect; PFO, 
patent foramen ovale; PDA, patent ductus arteriosus
Table 5 
Complications associated with diagnostic  
and therapeutic percutaneous procedures
Complications n = 1,002
Hematoma, n (%) 78 (7.8)
Fever, n (%) 76 (7.6)
Arrhythmias, n (%) 18 (1.8)
Cardiorespiratory arrest, n (%) 3 (0.3)
Prosthesis embolization, n (%) 3 (0.3)
Infundibular reaction, n (%) 3 (0.3)
Venous occlusion, n (%) 3 (0.3)
Death, n (%) 3 (0.3)
Cyanotic crises, n (%) 2 (0.2)
Retroperitoneal bleeding, n (%) 1 (0.1)
Arteriovenous fistula, n (%) 1 (0.1)
Iliac and femoral thrombosis, n (%) 1 (0.1)
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conclusions
The results of this study demonstrated the pre-
dominance of therapeutic procedures in patients with 
acyanotic congenital heart diseases performed with low 
complication rates in a tertiary referral centre.
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